Immortalized cells and one oncogene in malignant transformation: old insights on new explanation by Vadym M Kavsan et al.
CORRESPONDENCE Open Access
Immortalized cells and one oncogene in
malignant transformation: old insights on
new explanation
Vadym M Kavsan*, Anton V Iershov and Olena V Balynska
Abstract
Background: Nearly thirty years ago, it was first shown that malignant transformation with single oncogene
necessarily requires the immortal state of the cell. From that time this thesis for the cells of human origin was not
disproved. The basic point which we want to focus on by this short communication is the correct interpretation of
the results obtained on the widely used human embryonic kidney 293 (HEK293) cells.
Results: Intensive literature analysis revealed an increasing number of recent studies discovering new oncogenes
with non-overlapping functions. Since the 1970s, dozens of oncogenes have been identified in human cancer.
Cultured cell lines are often used as model systems in these experiments. In some investigations the results
obtained on such cells are interpreted by the authors as a malignant transformation of normal animal or even
normal human cells (as for example with HEK293 cells). However, when a cell line gains the ability to undergo
continuous cell division, the cells are not normal any more, they are immortalized cells. Nevertheless, the authors
consider these cells as normal human ones, what is basically incorrect. Moreover, it was early demonstrated that
the widely used human embryonic kidney 293 (HEK293) cells have a relationship to neurons.
Conclusions: Thus, the experiments with established cell lines reinforce the notion that immortality is an essential
requirement for malignant transformation that cooperates with other oncogenic changes to program the
neoplastic state and substances under such investigation should be interpreted as factors which do not
malignantly transform normal cells alone, but possess the ability to enhance the tumorigenic potential of already
immortalized cells.
In 1983, Newbold and Overell showed that the acquisi-
tion of the immortal state was required, although not
sufficient, for malignant transformation, thus proving
multistage model of cancer [1]. They had demonstrated
that an oncogene could cause malignant transformation
of immortalized NIH/3T3 cells. Further, many research
groups demonstrated that 2 oncogenes being introduced
simultaneously can cooperate in driving normal rodent
cells to neoplastic state, in these pairs one of oncogenes
induces immortality [2]. However, the transformation of
primary human cells by these oncogene pairs were
unsuccessful because of the differences in telomere biol-
ogy and regulation of cell senescence between human
and murine cells. As it was reviewed by Hahn, 2002 [3],
“these experiments reinforce the notion that immortality
is an essential requirement for transformation that
cooperates with other oncogenic changes to program
the neoplastic state”. In the June 2010 issue of BMC
Cell Biology, volume 11 in the article by Ha et al. [4]
the authors undertook their study with the aim to assess
whether human cervical cancer oncogene (HCCR-1)
overexpression alone converts normal human cells to
malignantly transformed cells. For this study, the
authors have chosen the human embryonic kidney 293
cells (also often referred to as 293 cells, HEK 293, or
less precisely HEK cells) as a model of normal human
cells. In conclusion, the authors wrote: “although
researchers have been able to transform normal mouse
cells into tumor forming cells by introducing several
cooperating oncogenes into these cells, human cells
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have been resistant to such transformation. In this
study, we converted normal cells into tumor cells by
delivering HCCR-1 alone in combination with no other
oncogenes”.
However, as it is widely known, 293 cells were gener-
ated by Graham et al. [5] in early 70s by transformation
of culture of normal human embryonic kidney cells with
sheared human adenovirus type 5 DNA. Further geno-
mic analysis showed that approximately 4.5 kilobases
from the left arm of the viral genome became incorpo-
rated into human chromosome 19, resulting in
decreased senescence of these cells [6]. Thus, HEK293 is
not a model for normal human cells; these cells are
immortalized already by known oncogene but not malig-
nant yet. Moreover, even NIH/3T3 cells, which authors
[4] also used for their conclusions are not really normal
mouse cells: NIH/3T3 cells originate from mouse
embryonic fibroblasts (MEF), which have the ability to
overcome cellular senescence and be spontaneously
immortalized when cultured under certain conditions
[7]. The mechanism of this immortalization was not
fully described, but it was proposed that p19ARF and
MDM2 functionally inactivate both p53 and pRb path-
ways involved in cell senescence [8]. NIH/3T3 can
be oncogenically transformed by Ras alone [9], while
for MEF transformation at least 2 oncogenes are neces-
sary [2].
Interesting, that similar investigations on HEK293 or
NIH/3T3 cell lines with other oncogenes which do not
overlap in their intracellular function also show conver-
sion into tumor cells with one oncogene alone [4,10-12].
It is quite difficult also to accept completely the inter-
pretation of authors that they observed transdifferentia-
tion in HEK293 cell line without further discussion. The
matter is that previously Shaw et al. [13] demonstrated
that “the widely used HEK293 cells have an unexpected
relationship to neurons, a finding that may require rein-
terpretation of many previous studies in which it was
assumed that HEK293 cells resembled more typical kid-
ney epithelial cells” and may not be used as an in vitro
model for kidney cell function.
Thus, the experiments with an established or immor-
talized cell line that has acquired the ability to prolifer-
ate indefinitely either through random mutation or
deliberate modification, such as ectopic expression of
different genes, reinforce the notion that immortality is
an essential requirement for transformation that coop-
erates with other oncogenic changes to program the
neoplastic state and that the substances under such kind
of investigations should be interpreted as factors (in par-
ticular, oncogenes or oncoproteins) which not malig-
nantly transform alone the normal cells, but possess the
ability to enhance the tumorigenic potential of already
immortalized cells.
Nevertheless, the article by Ha et al. [4] was published
very timely because the findings about the origin of
HEK293 and NIH/3T3 cell lines will require reinterpre-
tation of many previous studies in which it was assumed
that these and other immortalized cell lines resembled
typical normal human or rodent cells.
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